HLTRF
:US OTC

Add to watchlist
$12.99
Last updated:09/18/2020
HLTRF: US OTC
$12.99
HLS Therapeutics, Inc.

HLS Therapeutics, Inc. operates as a pharmaceutical company. It focuses on the acquisition and commercialization of late-stage development, commercial-stage promoted and established, branded pharmaceutical products in the North American markets. The company was founded by Gregory Gubitz, Gilbert Godin and William McDowall Wells on March 12, 2018 and is headquartered in Etobicoke, Canada.

Dividend yield
-
P/E ratio
-
Payout ratio
-
CASH payout ratio
-
Stock volatility (Beta)
past 12 months
Become our supporter to unlock all data!
warning-signBased on missed expected dividend payments we detected that dividend payouts might be suspended. Check the company website for further information.
HLTRF dividends
Create free account to unlock
Company results
Qtr
Ann
Fundamentals
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Company profile
CEO
Gregory Gubitz
Market capitalization
Small (0.41B)